These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 29676250)
41. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Maude RJ; Pontavornpinyo W; Saralamba S; Aguas R; Yeung S; Dondorp AM; Day NP; White NJ; White LJ Malar J; 2009 Feb; 8():31. PubMed ID: 19228438 [TBL] [Abstract][Full Text] [Related]
42. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Wongsrichanalai C; Meshnick SR Emerg Infect Dis; 2008 May; 14(5):716-9. PubMed ID: 18439351 [TBL] [Abstract][Full Text] [Related]
43. Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum. Falq G; Van Den Bergh R; De Smet M; Etienne W; Nguon C; Rekol H; Imwong M; Dondorp A; Kindermans JM Malar J; 2016 Sep; 15(1):446. PubMed ID: 27585957 [TBL] [Abstract][Full Text] [Related]
44. The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine. Djimde AA; Makanga M; Kuhen K; Hamed K Expert Rev Anti Infect Ther; 2015 Aug; 13(8):1031-45. PubMed ID: 26081265 [TBL] [Abstract][Full Text] [Related]
45. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers. Lim P; Dek D; Try V; Eastman RT; Chy S; Sreng S; Suon S; Mao S; Sopha C; Sam B; Ashley EA; Miotto O; Dondorp AM; White NJ; Su XZ; Char MC; Anderson JM; Amaratunga C; Menard D; Fairhurst RM Antimicrob Agents Chemother; 2013 Nov; 57(11):5277-83. PubMed ID: 23939897 [TBL] [Abstract][Full Text] [Related]
47. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia. Satimai W; Sudathip P; Vijaykadga S; Khamsiriwatchara A; Sawang S; Potithavoranan T; Sangvichean A; Delacollette C; Singhasivanon P; Kaewkungwal J; Lawpoolsri S Malar J; 2012 Aug; 11():300. PubMed ID: 22929621 [TBL] [Abstract][Full Text] [Related]
48. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum. Barnes KI; White NJ Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154 [TBL] [Abstract][Full Text] [Related]
49. Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009. Zwang J; Dorsey G; Mårtensson A; d'Alessandro U; Ndiaye JL; Karema C; Djimde A; Brasseur P; Sirima SB; Olliaro P Malar J; 2014 Mar; 13():114. PubMed ID: 24666562 [TBL] [Abstract][Full Text] [Related]
50. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Nosten F; van Vugt M; Price R; Luxemburger C; Thway KL; Brockman A; McGready R; ter Kuile F; Looareesuwan S; White NJ Lancet; 2000 Jul; 356(9226):297-302. PubMed ID: 11071185 [TBL] [Abstract][Full Text] [Related]
51. Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Talisuna AO; Karema C; Ogutu B; Juma E; Logedi J; Nyandigisi A; Mulenga M; Mbacham WF; Roper C; Guerin PJ; D'Alessandro U; Snow RW Lancet Infect Dis; 2012 Nov; 12(11):888-96. PubMed ID: 23099083 [TBL] [Abstract][Full Text] [Related]
52. Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling. Dini S; Zaloumis S; Cao P; Price RN; Fowkes FJI; van der Pluijm RW; McCaw JM; Simpson JA Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150462 [TBL] [Abstract][Full Text] [Related]
53. How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria. Dondorp AM; Smithuis FM; Woodrow C; Seidlein LV Trends Parasitol; 2017 May; 33(5):353-363. PubMed ID: 28187990 [TBL] [Abstract][Full Text] [Related]
54. Single-nucleotide polymorphisms of artemisinin resistance-related pfubp1 and pfap2mu genes in imported Plasmodium falciparum to Wuhan, China. Cheng W; Wu K; Song X; Wang W; Du W; Li J Infect Genet Evol; 2022 Jul; 101():105286. PubMed ID: 35470127 [TBL] [Abstract][Full Text] [Related]
55. Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions - India and sub-Saharan Africa. Arya A; Kojom Foko LP; Chaudhry S; Sharma A; Singh V Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():43-56. PubMed ID: 33556786 [TBL] [Abstract][Full Text] [Related]
56. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam. Thanh NV; Thuy-Nhien N; Tuyen NT; Tong NT; Nha-Ca NT; Dong LT; Quang HH; Farrar J; Thwaites G; White NJ; Wolbers M; Hien TT Malar J; 2017 Jan; 16(1):27. PubMed ID: 28086775 [TBL] [Abstract][Full Text] [Related]
57. [Elimination in South-East Asia? The role of antimalarial drugs]. Nosten F Bull Acad Natl Med; 2016 Mar; 200(3):467-75; discussion 475-6. PubMed ID: 28644000 [TBL] [Abstract][Full Text] [Related]
59. Artemisinin and multidrug-resistant Plasmodium falciparum - a threat for malaria control and elimination. Dhorda M; Amaratunga C; Dondorp AM Curr Opin Infect Dis; 2021 Oct; 34(5):432-439. PubMed ID: 34267045 [TBL] [Abstract][Full Text] [Related]
60. Expansion of a Specific Plasmodium falciparum PfMDR1 Haplotype in Southeast Asia with Increased Substrate Transport. Calçada C; Silva M; Baptista V; Thathy V; Silva-Pedrosa R; Granja D; Ferreira PE; Gil JP; Fidock DA; Veiga MI mBio; 2020 Dec; 11(6):. PubMed ID: 33262257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]